Mechanisms of isorhamnetin inhibition of osteoclast differentiation: insights from molecular dynamics simulations and <i>in vitro</i>/<i>in vivo</i> experiments.

Front Pharmacol · 2025 · PMC12066772 · PMID 40356982

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

However, these markers displayed a decreasing trend following Iso administration, with the most notable reduction observed at the higher Iso dose (40 mg/kg).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Mechanisms of isorhamnetin inhibition of osteoclast differentiation: insights from molecular dynamics simulations and &lt;i&gt;in vitro&lt;/i&gt;/&lt;i&gt;in vivo&lt;/i&gt; experiments.

The sentences

Mechanisms of isorhamnetin inhibition of osteoclast differentiation: insights from molecular dynamics simulations and <i>in vitro</i>/<i>in vivo</i> experiments.